SCHEMBL23309512

SCHEMBL23309512

N#Cc1cccc(NC(=O)c2cc(F)nc(F)c2F)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 1/20 0.57
▸ GRM4 Q14833 1/20 0.53
▸ P2RX1 P51575 1/20 0.53
▸ EGLN1 Q9GZT9 1/20 0.53
▸ MEN1 O00255 3/20 0.49
▸ MAPT P10636 3/20 0.49
▸ KMT2A Q03164 3/20 0.49
▸ ALDH1A1 P00352 1/20 0.49
▸ GRM5 P41594 1/20 0.48
▸ GAA P10253 2/20 0.47
▸ NPC1 O15118 1/20 0.47
▸ RAB9A P51151 1/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.47
▸ NR1H4 Q96RI1 1/20 0.47
▸ PDK1 Q15118 1/20 0.46
▸ PDK2 Q15119 1/20 0.46
▸ PDK3 Q15120 1/20 0.46
▸ PDK4 Q16654 1/20 0.46
▸ ALOX15 P16050 1/20 0.46
▸ CASP7 P55210 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23309521 0.86 GRM5 (0.51) HTTEGLN1MEN1MAPTKMT2A
SCHEMBL23309490 0.81 GAA (0.51) HTTMEN1KMT2AALDH1A1GAA
SCHEMBL23309536 0.81 MEN1 (0.55) MEN1KMT2AALDH1A1GAANPC1
SCHEMBL23309548 0.81 FADS1 (0.55) HTTGRM4P2RX1MEN1MAPT
SCHEMBL23309730 0.79 KMT2A (0.47) HTTP2RX1MEN1MAPTKMT2A
SCHEMBL23309568 0.79 P2RX1 (0.59) HTTP2RX1MEN1MAPTKMT2A
SCHEMBL23309501 0.78 FADS1 (0.56) MEN1KMT2ASMN1; SMN2RXFP1
SCHEMBL23309513 0.78 RAB9A (0.63) GRM4MEN1KMT2AALDH1A1GAA
SCHEMBL23309703 0.76 RAB9A (0.51) HTTMEN1KMT2AALDH1A1NPC1
SCHEMBL23309555 0.74 HTT (0.55) HTTNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210120817-A1 PLANT DISEASE CONTROL AGENT MEIJI SEIKA PHARMA CO., LTD. (JP) 2021-04-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210120817-A1 PLANT DISEASE CONTROL AGENT BROX, ALG1, CTRL HTT 2558/4885GRM4 2885/4885P2RX1 2860/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback